About ArtProtein
A U.S.-based biologics CDMO that combines deep scientific expertise with practical development experience to move your molecules from idea to manufacturable reality.
Science-driven development, built for your program
ArtProtein was founded on the belief that biologics development should be rigorous, transparent, and efficient. We work as an extension of your team — applying proven science and systematic thinking to advance your molecule with confidence, whether it's destined for human therapeutic use or veterinary and animal-health (USDA 9CFR) programs.
Our team brings 15+ years of cross-functional experience in cell line engineering on the CHO-art and HEK-art expression platforms, upstream and downstream development, analytical sciences, and regulatory support — running multiple programs simultaneously. Whether you're a biotech startup with a first candidate or an established organization looking to outsource development, ArtProtein has the experience to help you succeed.
Science first
Every decision is grounded in data. We apply DoE methodology, structured development reviews, and rigorous analytics to ensure your process is built on solid science.
Transparent partnership
You get full visibility into your program. We share our data, reasoning, and recommendations openly — so you can make informed decisions at every stage.
Efficiency by design
We design our workflows to eliminate waste and accelerate your timeline. Systematic planning, experienced judgment, and clear milestones keep your program on track.
Want to learn more?
Tell us about your molecule and program goals. We'll outline how ArtProtein can help.